Winfield Associates’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-115
Closed -$7K 309
2017
Q4
$7K Buy
115
+20
+21% +$994 ﹤0.01% 472
2017
Q3
$5K Sell
95
-5
-5% -$238 ﹤0.01% 493
2017
Q2
$5K Buy
100
+20
+25% +$921 ﹤0.01% 516
2017
Q1
$3K Sell
80
-10
-11% -$413 ﹤0.01% 532
2016
Q4
$4K Hold
90
﹤0.01% 462
2016
Q3
$4K Hold
90
﹤0.01% 427
2016
Q2
$4K Sell
90
-10
-10% -$431 ﹤0.01% 421
2016
Q1
$4K Buy
+100
New +$4.23K ﹤0.01% 402

Other funds holding FMS

Winfield Associates's FMS Position: Q1 2018 in Review

Winfield Associates sold out of Fresenius Medical Care (FMS) in Q1 2018, closing a stake of 115 shares — an estimated $7K sold.

Winfield Associates first reported a position in FMS in Q1 2016 and held it in 8 quarters. The position peaked at $7K in Q4 2017. 233 funds tracked by Wall St. Rank hold FMS as of Q1 2018.

  • Winfield Associates reported no remaining Fresenius Medical Care position as of Q1 2018 after selling out during the quarter.
  • Winfield Associates sold 115 Fresenius Medical Care shares in Q1 2018, an estimated $7K.
  • Winfield Associates first reported a position in Fresenius Medical Care in Q1 2016 and held it in 8 quarters.
  • Winfield Associates's Fresenius Medical Care position peaked at $7K in Q4 2017.
  • 233 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q1 2018.

Based on Winfield Associates's 13F filing for Q1 2018, filed 10 May 2018.